Large-scale testing (Phase 3)Study completedNCT06729593
What this trial is testing
Remdesivir for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)
Who this might be right for
Covid19
National Institute of Allergy and Infectious Diseases (NIAID) 87